134 related articles for article (PubMed ID: 20152524)
1. Novel targeted therapies for prostate cancer.
Macfarlane RJ; Chi KN
Urol Clin North Am; 2010 Feb; 37(1):105-19, Table of Contents. PubMed ID: 20152524
[TBL] [Abstract][Full Text] [Related]
2. New therapies for castration-resistant prostate cancer: efficacy and safety.
Beltran H; Beer TM; Carducci MA; de Bono J; Gleave M; Hussain M; Kelly WK; Saad F; Sternberg C; Tagawa ST; Tannock IF
Eur Urol; 2011 Aug; 60(2):279-90. PubMed ID: 21592649
[TBL] [Abstract][Full Text] [Related]
3. Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer.
Edwards J
Expert Opin Investig Drugs; 2010 May; 19(5):605-14. PubMed ID: 20367532
[TBL] [Abstract][Full Text] [Related]
4. Targeting continued androgen receptor signaling in prostate cancer.
Massard C; Fizazi K
Clin Cancer Res; 2011 Jun; 17(12):3876-83. PubMed ID: 21680543
[TBL] [Abstract][Full Text] [Related]
5. New drugs in prostate cancer.
Armstrong AJ; Carducci MA
Curr Opin Urol; 2006 May; 16(3):138-45. PubMed ID: 16679849
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor: role and novel therapeutic prospects in prostate cancer.
Taplin ME
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1495-508. PubMed ID: 18759700
[TBL] [Abstract][Full Text] [Related]
7. Abiraterone acetate for castration resistant prostate cancer.
Shah S; Ryan C
Expert Opin Investig Drugs; 2010 Apr; 19(4):563-70. PubMed ID: 20225998
[TBL] [Abstract][Full Text] [Related]
8. The role of fibroblast growth factors and their receptors in prostate cancer.
Kwabi-Addo B; Ozen M; Ittmann M
Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
[TBL] [Abstract][Full Text] [Related]
9. Emerging treatment options for patients with castration-resistant prostate cancer.
George D; Moul JW
Prostate; 2012 Feb; 72(3):338-49. PubMed ID: 21748753
[TBL] [Abstract][Full Text] [Related]
10. Novel targeted pro-apoptotic agents for the treatment of prostate cancer.
Huang X; Zhang X; Farahvash B; Olumi AF
J Urol; 2007 Nov; 178(5):1846-54. PubMed ID: 17868738
[TBL] [Abstract][Full Text] [Related]
11. Insulin-Like Growth Factor (IGF) family and prostate cancer.
Gennigens C; Menetrier-Caux C; Droz JP
Crit Rev Oncol Hematol; 2006 May; 58(2):124-45. PubMed ID: 16387509
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial androgen receptor targeted therapy for prostate cancer.
Singh P; Uzgare A; Litvinov I; Denmeade SR; Isaacs JT
Endocr Relat Cancer; 2006 Sep; 13(3):653-66. PubMed ID: 16954423
[TBL] [Abstract][Full Text] [Related]
13. Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.
Chi KN; Bjartell A; Dearnaley D; Saad F; Schröder FH; Sternberg C; Tombal B; Visakorpi T
Eur Urol; 2009 Oct; 56(4):594-605. PubMed ID: 19560857
[TBL] [Abstract][Full Text] [Related]
14. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
15. Mammalian target of rapamycin: a new target in prostate cancer.
Rai JS; Henley MJ; Ratan HL
Urol Oncol; 2010; 28(2):134-8. PubMed ID: 19523861
[TBL] [Abstract][Full Text] [Related]
16. Targeting the apoptosis pathway in prostate cancer.
Zielinski RR; Eigl BJ; Chi KN
Cancer J; 2013; 19(1):79-89. PubMed ID: 23337761
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein.
Dorai T; Gehani N; Katz A
Mol Urol; 2000; 4(1):1-6. PubMed ID: 10851300
[TBL] [Abstract][Full Text] [Related]
18. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.
McCarty MF
Integr Cancer Ther; 2004 Dec; 3(4):349-80. PubMed ID: 15523106
[TBL] [Abstract][Full Text] [Related]
19. National cooperative group trials.
Dipaola RS; Thompson IM
Urology; 2005 May; 65(5 Suppl):23-9; discussion 29. PubMed ID: 15885277
[TBL] [Abstract][Full Text] [Related]
20. Novel drugs targeting the androgen receptor pathway in prostate cancer.
Mateo J; Smith A; Ong M; de Bono JS
Cancer Metastasis Rev; 2014 Sep; 33(2-3):567-79. PubMed ID: 24390422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]